Get Healthy!

GLP-1 Weight Loss Drugs May Lower the Risk for 14 Obesity-Related Cancers

A new study finds women taking GLP-1 Receptor agonists were significantly less likely to develop obesity-related cancers.

HealthDay
Health News is provided as a service to Byard-Mercer Pharmacy site users by HealthDay. Byard-Mercer Pharmacy nor its employees, agents, or contractors, review, control, or take responsibility for the content of these articles. Please seek medical advice directly from your pharmacist or physician.
Copyright © 2025 HealthDay All Rights Reserved.